Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AGADA Biosciences

AGADA Biosciences
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
$26.3K LATEST DEAL AMOUNT
3 INVESTORS
Description

Provide of orphan drug development services. The company provide centralized preclinical drug efficacy testing and phenotyping services for neuromuscular disorders, with a specific expertise in murine models of duchenne muscular dystrophy.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • 1344 Summer Street
  • Suite 312
  • Halifax, Nova Scotia B3H 0A8
  • Canada

+1 (902) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AGADA Biosciences’s full profile, request a free trial.

AGADA Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 21-Oct-2014 $26.3K 000.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

AGADA Biosciences Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BioNova Accelerator/Incubator Minority 000 0000 000000 0
Global Business Accelerator Program Other 000 0000 000000 0
Innovacorp Venture Capital Minority 000 0000 000000 0

AGADA Biosciences Executive Team (2)

Name Title Board
Seat
Contact
Info
Eric Hoffman Ph.D Co-Founder & Vice President
Kanneboyina Nagaraju Ph.D Co-Founder & President